EQUITEC PROPRIETARY MARKETS, LLC - CELLULAR BIOMEDICINE GROUP I ownership

Back to all holdings Add to watchlist

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
EQUITEC PROPRIETARY MARKETS, LLC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$364,000
-32.2%
19,800
-32.4%
0.10%
-76.8%
Q3 2020$537,000–29,300–0.41%–
 Download
Other shareholders

There were no reported owners of CELLULAR BIOMEDICINE GROUP I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders